Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cryoport Inc
(NQ:
CYRX
)
8.860
+0.290 (+3.38%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Cryoport Inc
< Previous
1
2
3
4
Next >
Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday
November 07, 2022
Gainers
Via
Benzinga
What 4 Analyst Ratings Have To Say About CryoPort
July 12, 2022
CryoPort (NASDAQ:CYRX) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Why Yelp Shares Are Trading Lower By 15%? Here Are 86 Stocks Moving In Friday's Mid-Day Session
November 04, 2022
Gainers
Via
Benzinga
CryoPort Approves $100M Buyback Program
March 11, 2022
CryoPort Inc's (NASDAQ: CYRX) Board has authorized a repurchase program. Per the program, CryoPort may repurchase up to $100 million of its outstanding...
Via
Benzinga
CryoPort: Q4 Earnings Insights
February 24, 2022
CryoPort (NASDAQ:CYRX) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
What 5 Analyst Ratings Have To Say About CryoPort
January 19, 2022
Over the past 3 months, 5 analysts have published their opinion on CryoPort (NASDAQ:
Via
Benzinga
Whither Small Caps After Fed’s Tough Talk?
August 29, 2022
For now its better not to “Fight the Fed” because they are fighting the with the market. Now that everyone is scared of the Fed's rhetoric it would be better to wait a week or so as more data and...
Via
Talk Markets
CryoPort Earnings Perspective: Return On Capital Employed
August 23, 2022
According to Benzinga Pro data, during Q2, CryoPort (NASDAQ:CYRX) posted sales of $64.15 million. Earnings were up 31.54%, but CryoPort still reported an overall loss of $9.18 million.
Via
Benzinga
Check your Portfolio for Small Cap Weighting: Growth, Innovation or Speculation?
August 15, 2022
The SPDR S&P Biotech ETF remains our key indicator for small cap biotechs. It is up 14.55% over one month at $93.78 but is still down 16% YTD. The Russell 2000 is up 16.5% over one month mirroring...
Via
Talk Markets
Cryoport Stock Shows Market Leadership With Jump To 91 RS Rating
August 08, 2022
On Monday, Cryoport stock hit a key technical milestone, with its Relative Strength Rating upgraded to 91, a rise from 82 the day before.
Via
Investor's Business Daily
Recap: CryoPort Q2 Earnings
August 04, 2022
CryoPort (NASDAQ:CYRX) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings CryoPort missed estimated earnings...
Via
Benzinga
Recap: CryoPort Q3 Earnings
November 04, 2021
CryoPort (NASDAQ:CYRX) reported its Q3 earnings results on Thursday, November 4, 2021 at 04:05 PM. Here's what investors need to know about the announcement. Earnings CryoPort...
Via
Benzinga
CryoPort's Earnings: A Preview
August 03, 2022
CryoPort (NASDAQ:CYRX) is set to give its latest quarterly earnings report on Thursday, 2022-08-04. Here's what investors need to know before the announcement. Analysts estimate that CryoPort will...
Via
Benzinga
Small Cap Biotechs Regain Momentum
July 11, 2022
Smaller cap biotech stocks soared off from recent lows looking like a redux of early 2021 when prices were double that of current values.
Via
Talk Markets
CryoPort Earnings Perspective: Return On Invested Capital
May 26, 2022
According to data from Benzinga Pro, during Q1, CryoPort's (NASDAQ:CYRX) reported sales totaled $52.30 million. Despite a 94.85% increase in earnings, the company posted a loss of $13.40 million.
Via
Benzinga
Expert Ratings for CryoPort
May 06, 2022
Over the past 3 months, 5 analysts have published their opinion on CryoPort (NASDAQ:CYRX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
Earnings Preview For CryoPort
May 04, 2022
CryoPort (NASDAQ:CYRX) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that CryoPort will...
Via
Benzinga
Biotech Playbook 2021 Part 2: Rotation Rally Brings Relief after FED Pivot
December 22, 2021
The new aggressive Fed taper combined with a rise in interest rates for 2022 adds a new element of risk to portfolio management. Monetary policy is a headwind for 2022.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2022
January 19, 2022
Upgrades For Rocket Companies Inc (NYSE:RKT), JP Mo...
Via
Benzinga
Biotech Playbook 2021: No Help From Small Caps In Q4
December 14, 2021
Mid-cap stock picks have done better today but are way off their 2021 highs. Cryoport and Veracyte are still up and look better technically. Quidel was up 5.48% today on Omicron concerns globally but...
Via
Talk Markets
Biotech Stocks are Due for a Rally
November 22, 2021
There are many rebalancing trades left in your stock portfolio but biotech is in the doldrums.
Via
Talk Markets
4 Stocks Insiders Are Selling
November 19, 2021
When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to...
Via
Benzinga
Looking for Growth in Small and Mid Cap Life Science Stocks
November 15, 2021
2021 is an unusual year for biotech with a “blow-off” February high in speculative small caps.
Via
Talk Markets
CryoPort Inc (CYRX) Q3 2021 Earnings Call Transcript
November 04, 2021
CYRX earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
3 Under-the-Radar COVID Stocks
October 20, 2021
Some COVID-19 stocks are pretty famous. But other lesser-known names are flying high, too.
Via
The Motley Fool
Exposures
COVID-19
Chief Financial Officer Of Cryoport Trades $3.8M In Company Stock
October 18, 2021
Robert Stefanovich, Chief Financial Officer at Cryoport (NASDAQ:CYRX), made a large buy and sell of company shares on October 14, according to a new SEC filing. What Happened: A...
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Biotech Playbook Revisited As Technicals Weaken
September 27, 2021
Recent breakthroughs with mRNA vaccines over the past two years have shown the enormous potential for transformative therapies. DNA sequencing took off five years ago and new applications are still...
Via
Talk Markets
Small Cap Biotechs Sagging But More Deals Are Likely to Perk Up the Market
September 09, 2021
Despite record highs in the Nasdaq recently at the 15,000 level the biotech market seems sluggish. Speculation has ebbed. As if we need a green screen every day.
Via
Talk Markets
Return on Capital Employed Overview: CryoPort
August 31, 2021
After pulling data from Benzinga Pro it seems like during Q2, CryoPort (NASDAQ:CYRX) brought in sales totaling $56.19 million. However, earnings decreased 228.2%, resulting in a...
Via
Benzinga
5 Stocks Insiders Are Selling
August 27, 2021
When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.